Benchmark reiterates Buy on Trade Desk stock, cites oversold valuation

Benchmark reiterated a Buy rating on The Trade Desk with a $40 price target, implying upside from the current $24.12 share price, but the stock remains down 57% over the past year and trades at 7.8x EV/NTM EBITDA. The note highlights roughly 12% adjusted EBITDA growth through 2027, though 13 analysts have recently cut earnings estimates and the company is facing cautious demand commentary, AI-related competition concerns, and management turnover. Overall, the article is a mixed read: valuation support is offset by downward estimate revisions and execution risk.

Analysis

The setup looks less like a clean value rebound and more like a debate over whether the market has already priced in a full cycle of estimate compression. At roughly 7.8x forward EV/EBITDA, TTD is being valued as if growth is durable but operating leverage is structurally impaired; that creates asymmetry if ad budgets reaccelerate, but it also means the stock can stay cheap for longer if consensus keeps drifting lower. The key second-order issue is that “AI investment” is now being used as both a growth narrative and a margin excuse, which makes management credibility a binary input for multiple expansion.

The more important catalyst is not the next quarter’s print but whether large advertisers interpret platform audits, exec turnover, and competitive AI pressure as reasons to diversify spend. If even a modest share of demand migrates to incumbent walled gardens or lower-funnel channels, TTD’s margin recovery path gets pushed out by multiple quarters because fixed-cost leverage is the whole earnings story. Conversely, if the feared demand leakage does not show up, the current downgrade wave could prove self-correcting and force a sharp cover rally.

The contrarian read is that the market may be over-penalizing governance noise relative to actual revenue durability. A 50%+ drawdown has already embedded a lot of skepticism, so incremental downside from another small estimate cut is likely smaller than the upside from a single clean quarter that shows spend resilience and no further margin reset. The risk is that sentiment remains hostage to every external headline, so the name may trade like a “prove it” story for the next 1-2 quarters rather than a fundamentals-first compounder.

Key Decisions for Investors

• Maintain a tactical long only via call spreads: buy TTD 3-6 month call spreads around current levels to express mean reversion without taking full multiple-risk; target 2:1+ payoff if the next print stabilizes estimates.
• For fundamental longs, wait for confirmation: add on any post-earnings gap down only if management holds EBITDA margin guidance and revenue does not materially miss; otherwise expect another leg lower from estimate revisions.
• Pair trade: long META / short TTD over the next 1-3 months to express the risk that ad dollars continue consolidating toward scaled ecosystems while TTD remains a credibility-risk story.
• If you are already long TTD, hedge with near-dated puts into the next earnings window; the stock’s beta to negative estimate revisions is still high, and downside can reprice quickly on guidance nuance.
• Contrarian long entry point: look for a capitulation setup below current valuation if the stock trades down on non-fundamental headlines but sell-side revisions stop; that would create a favorable 12-month asymmetry.